Evotec appoints Joanna Holbrook as chief scientific officer: Evotec stock pre-market at EUR 2.56
Published on 10/16/2026 at 08:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAppointment and reporting dates
- Joanna Holbrook is scheduled to become Evotec’s chief scientific officer and management board member on November 1, 2026.
- Evotec stock trades pre-market at EUR 2.56 at 8:00 a.m. CEST at Lang & Schwarz on October 16, 2026.
- Evotec has scheduled publication of its third-quarter and nine-month results for November 5, 2026.
Evotec SE announced on October 15, 2026, that Dr. Joanna Holbrook will become chief scientific officer and a member of the management board effective November 1, 2026. The company said Holbrook brings more than 25 years of scientific and research-and-development leadership experience. The announcement was included in a Form 6-K filed with the U.S. Securities and Exchange Commission.
Evotec stock is at EUR 2.56 pre-market at Lang & Schwarz on October 16, 2026, at 8:00 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Evotec stock.
What matters today
Holbrook’s appointment is scheduled to take effect on November 1, 2026. A round-number level of EUR 3.00 is 17.19 percent above the pre-market price. Evotec has scheduled publication of its third-quarter and nine-month results for November 5, 2026.
Market context: Market report DAX.
